Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Ebiomedicine|September 18, 2024
Phosphoproteomics predict response to midostaurin plus chemotherapy in independent cohorts of FLT3-mutated acute myeloid leukaemiaWeronika E Borek, Luis Nobre, S Federico Pedicona, et al.
Nature|January 7, 2015
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutationsKai Deng, Mihaela Pertea, Anthony Rongvaux, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 9, 2021
Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center ExperienceAlexander Ambinder, Matthew Smith, Hua-Ling Tsai, et al.
Blood Advances|May 20, 2026
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML including TP53-mutated diseaseNour Sabiha Naji, Taha Soueidatt Ahmedna, Xinghan Zeng, et al.
Nature Communications|June 28, 2019
Noncoding dsRNA induces retinoic acid synthesis to stimulate hair follicle regeneration via TLR3Dongwon Kim, Ruosi Chen, Mary Sheu, et al.
Blood Advances|October 20, 2020
Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamideJonathan A Webster, Leo Luznik, Hua-Ling Tsai, et al.
Transplantation and Cellular Therapy|January 1, 2023
Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 YearsJonathan A Webster, Madison Reed, Hua-Ling Tsai, et al.
Nature Communications|October 1, 2022
Cell-specific regulation of gene expression using splicing-dependent frameshiftingJonathan P Ling, Alexei M Bygrave, Clayton P Santiago, et al.
Pageof 10